C. Casasola

Renal function of cancer patients "fit" for Cisplatin chemotherapy: physician perspective.

Amparo, G. Cristal-Luna, J. Montoya, 2014, The Gulf journal of oncology.

Randomized Trial of Alemtuzumab for Prevention of Graft Rejection and Preservation of Renal Function after Kidney Transplantation1

D. Machin, R. Calne, H. Lou, 2005, Transplantation.

Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study

M. Kim, K. Shu, A. Ingsathit, 2021, Clinical transplantation.

Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors.

E. Cordero, R. Danguilan, C. Casasola, 2012, Transplantation proceedings.

Living Donor Nephrectomy at the National Kidney and Transplant Institute: Surgical Techniques, Perioperative Complications and Outcomes

C. Casasola, 2017 .

Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.

A. S. Muñoz, R. Danguilan, E. Ona, 2008, Transplantation proceedings.

Safety And Efficacy Of Campath-1h (mabcampath®) With Low Dose Cyclosporine Monotherapy In Patients Receiving Kidney Transplants- 6 Month Analysis Of The Pilot Randomised Controlled Trial

R. Calne, J. Seldrup, H. Lou, 2004 .